Location History:
- Beech Grove, IN (US) (2000 - 2007)
- Indianapolis, IN (US) (2010 - 2024)
Company Filing History:
Years Active: 2000-2025
Title: Innovations and Contributions of Jolie Anne Bastian
Introduction
Jolie Anne Bastian is a prolific inventor based in Indianapolis, IN, recognized for her significant contributions to the field of pharmaceuticals. With an impressive portfolio of 30 patents, Bastian has made a notable impact on the development of selective estrogen receptor degraders.
Latest Patents
Among her latest patents, Jolie Anne Bastian has developed novel selective estrogen receptor degraders (SERDs). These innovative compounds are characterized by the formula: pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. In these formulations, either R or R' is independently selected from Cl, F, —CF, or —CH, while the other is hydrogen. The methods for their use are also meticulously detailed, showcasing Bastian's expertise in pharmaceutical innovations.
Career Highlights
Bastian’s career is marked by her role at Eli Lilly and Company, where she actively contributes to cutting-edge research and development. Her work focuses on creating therapeutic solutions that address various health challenges, particularly in hormone-related conditions.
Collaborations
Throughout her career, Jolie Anne Bastian has collaborated with notable colleagues, including Daniel Jon Sall and Theo Schotten. These partnerships reflect a commitment to advancing scientific knowledge and producing innovative solutions within the pharmaceutical landscape.
Conclusion
Jolie Anne Bastian's work exemplifies the spirit of innovation in the pharmaceutical industry. With her extensive patent portfolio and collaborative approach, she continues to drive advancements that contribute to improved healthcare solutions.